News

October 13, 2008 – At TCT 2008, Boston Scientific Corp. announced results from an analysis of nearly 7,500 patients from ...

Home October 12, 2008
Home
News

October 12, 2008 – Research results indicate that optical coherence tomography (OCT) may be the best tool available to detect vulnerable plaque (VP) in coronary arteries, according to findings that will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

Home October 12, 2008
Home
News

October 13, 2008 - GE Healthcare and Boston Scientific Corp. agreed to collaborate to improve intravascular ultrasound ...

Home October 12, 2008
Home
News

October 13, 2008 - Boston Scientific Corp. released comprehensive data for the TAXUS ATLAS clinical program, a series of ...

Home October 12, 2008
Home
News

October 13, 2008 – Piedmont Hospital in Atlanta, GA, is installing the Aquilion ONE from Toshiba America Medical Systems ...

Home October 12, 2008
Home
News

October 13, 2008 - Of those treated with Medtronic’s Endeavor Resolute drug-eluting stent (DES) in the RESOLUTE IDE ...

Home October 12, 2008
Home
News

October 10, 2008 - A recent study published in the October issue of Journal of Neuroimaging showed CT angiography (CTA) ...

Home October 09, 2008
Home
News

October 10, 2008 - TeraRecon Inc. this weekend will release new innovations in its flagship Aquarius iNtuition platform ...

Home October 09, 2008
Home
Technology

October 10, 2008 - Boston Scientific Corp. today said it received FDA approval to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System and the company plans to launch the stent early next month in the U.S.

Home October 09, 2008
Home
News

October 8, 2008 – To evaluate patient safety and quality care benefits of medical devices that share data with EMRs ...

Home October 08, 2008
Home
News

October 9, 2008 - A report on initial clinical experiences with Prescient Medical’s vProtect Luminal Shield in patients ...

Home October 08, 2008
Home
News

October 9, 2008 - Datascope Corp. said today it will sponsor a 300-patient, randomized clinical trial in high-risk acute ...

Home October 08, 2008
Home
News

October 9, 2008 - Lumen Biomedical Inc. said today the FDA cleared the LBI Embolectomy System for use in the removal of ...

Home October 08, 2008
Home
News

October 9, 2008 – Endosense this week launched the TOCCATA (TOuCh for CATheter Ablation) clinical study to evaluate the ...

Home October 08, 2008
Home
News

October 9, 2008 - Boston Scientific Corp. yesterday said it completed enrollment in the PERSEUS trial, designed to ...

Home October 08, 2008
Home
Subscribe Now